[1]Bo XW, Lu F, Xu HX, et al. Thermal ablation of benign thyroid nodules and papillary thyroid microcarcinoma[J]. Front Oncol, 2020, 10: 580431.
[2]Smulever A, Pitoia F. High rate incidence of postsurgical adverse events in patients with lowrisk papillary thyroid cancer who did not accept active surveillance[J]. Endocrine, 2020, 69(3): 587-595.
[3]Beer E. Removal of neoplasms of the urinary bladder; a new method, employing highfrequency (oudin) currents through a catheterizing cystoscope[J]. Am J Med, 1952, 13(5): 542-543.
[4]Wong KP, Lang BH. Use of radiofrequency ablation in benign thyroid nodules: A literature review and updates[J]. Int J Endocrinol, 2013, 2013: 428363.
[5]Jin H, Fan J, Liao K, et al. A propensity score matching study between ultrasoundguided percutaneous microwave ablation and conventional thyroidectomy for benign thyroid nodules treatment[J]. Int J Hyperthermia, 2018, 35(1): 232-238.
[6]Gharib H, Papini E, Paschke R, et al. American association of clinical endocrinologists, associazione medici endocrinologi, and europeanthyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules[J]. Endocr Pract, 2010, 16 Suppl 1: 1-43.
[7]Cao XJ, Liu J, Zhu YL, et al. Efficacy and safety of thermal ablation for solitary t1bn0m0 papillary thyroid carcinoma: A multicenter study[J]. J Clin Endocrinol Metab, 2021, 106(2): e573-e581.
[8]Chen J, Cao J, Qiu F, et al. The efficacy and the safety of ultrasoundguided ablation therapy for treating papillary thyroid microcarcinoma[J]. J Cancer, 2019, 10(21): 5272-5282.
[9]Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: Mechanism of action, clinical results, and devices[J]. J Vasc Interv Radiol, 2010, 21(8 Suppl): S192-S203.
[10]Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: Korean society of thyroid radiology[J]. Korean J Radiol, 2018, 19(4): 632-655.
[11]葛明华, 徐栋, 杨安奎, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版)[J]. 中国肿瘤, 2018, 27(10): 768-773.
[12]中国医师协会超声医师分会.甲状腺微小乳头状癌热消融诊疗指征专家共识[J]. 中华医学超声杂志(电子版), 2019, 16(8): 571-574.
[13]Mauri G, Hegedus L, Bandula S, et al. European thyroid association and cardiovascular and interventional radiological society of europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions[J]. Eur Thyroid J, 2021, 10(3): 185-197.
[14]Orloff LA, Noel JE, Stack BC Jr, et al. Radiofrequency ablation and related ultrasoundguided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the american head and neck society endocrine surgery section with the asia pacific society of thyroid surgery, associazione medici endocrinologi, british association of endocrine and thyroid surgeons, european thyroid association, italian society of endocrine surgery units, korean society of thyroid radiology, latin american thyroid society, and thyroid nodules therapies association[J]. Head Neck, 2022, 44(3): 633-660.
[15]Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm[J]. Radiology, 2015, 276(3): 909-918.
[16]Choi Y, Jung SL, Bae JS, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: A singlecenter propensity score matching study[J]. Int J Hyperthermia, 2019, 36(1): 359-367.
[17]Chung SR, Baek JH, Choi YJ, et al. Longerterm outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer[J]. Eur Radiol, 2019, 29(9): 4897-4903.
[18]Yoshida Y, Horiuchi K, Okamoto T. Patients′view on the management of papillary thyroid microcarcinoma: Active surveillance or surgery[J]. Thyroid, 2020, 30(5): 681-687.
[19]Haugen BR, Alexander EK, Bible KC, et al. 2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.
[20]Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasoundguided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma[J]. Clin Radiol, 2019, 74(9): 712-717.
[21]Cho SJ, Baek SM, Lim HK, et al. Longterm followup results of ultrasoundguided radiofrequency ablation for lowrisk papillary thyroid microcarcinoma: More than 5year followup for 84 tumors[J]. Thyroid, 2020, 30(12): 1745-1751.
[22]Cao XJ, Yu MA, Zhu YL, et al. Ultrasoundguided thermal ablation for papillary thyroid microcarcinoma: A multicenter retrospective study[J]. Int J Hyperthermia, 2021, 38(1): 916-922.
[23]Zhang M, Tufano RP, Russell JO, et al. Ultrasoundguided radiofrequency ablation versus surgery for lowrisk papillary thyroid microcarcinoma: Results of over 5 years′followup[J]. Thyroid, 2020, 30(3): 408-417.
[24]Jeon MJ, Kim WG, Choi YM, et al. Features predictive of distant metastasis in papillary thyroid microcarcinomas[J]. Thyroid, 2016, 26(1): 161-168.
[25]de Baère T, Auperin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: Experience in 566 patients with 1037 metastases[J]. Ann Oncol, 2015, 26(5): 987-991.
[26]Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: A multicenter american college of radiology imaging network trial[J]. Cancer, 2010, 116(4): 989-997.
[27]Cazzato RL, Jennings JW, Autrusseau PA, et al. Percutaneous imageguided cryoablation of spinal metastases: Over 10year experience in two academic centers[J]. Eur Radiol, 2022, 32(6): 4137-4146.
[28]Barat M, Tselikas L, de Baere T, et al. Thermalablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma[J]. Eur J Radiol, 2019, 119: 108650.
[29]Han K, Kim JH, Yang SG, et al. A singlecenter retrospective analysis of periprocedural variables affecting local tumor progression after radiofrequency ablation of colorectal cancer liver metastases[J]. Radiology, 2021, 298(1): 212-218.
[30]Shyn PB, Mauri G, Alencar RO, et al. Percutaneous imagingguided cryoablation of liver tumors: Predicting local progression on 24hour mri[J]. AJR Am J Roentgenol, 2014, 203(2): W181-191.
[31]Tuttle RM, Haugen B, Perrier ND. Updated american joint committee on cancer/tumornodemetastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): What changed and why?[J]. Thyroid, 2017, 27(6): 751-756.
[32]Anderson KL, Jr., Youngwirth LM, Scheri RP, et al. T1a versus T1b differentiated thyroid cancers: Do we need to make the distinction?[J]. Thyroid, 2016, 26(8): 1046-1052.
[33]Xiao J, Zhang Y, Zhang M, et al. Ultrasonographyguided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study[J]. Clin Endocrinol (Oxf), 2021, 94(4): 684-691.
[34]He H, Wu R, Zhao J, et al. Ultrasoundguided radiofrequency ablation versus surgical resection for the treatment of T1bN0M0 papillary thyroid carcinoma in different age groups[J]. Front Endocrinol (Lausanne), 2021, 12: 734432.
[35]Jaber T, Dadu R, Hu MI. Medullary thyroid carcinoma[J]. Curr Opin Endocrinol Diabetes Obes, 2021, 28(5): 540-546.
[36]Biamonte E, Solbiati L, Ierace T, et al. Medullary thyroid carcinoma treated with percutaneous ultrasoundguided radiofrequency ablation[J]. Endocrine, 2019, 65(3): 515-519.
[37]Wells SA Jr, Asa SL, Dralle H, et al. Revised american thyroid association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6): 567-610.
[38]陈宝定, 赵双双, 陈延玮, 等. 未分化甲状腺癌分子机制和治疗进展[J]. 江苏大学学报(医学版), 2021, 31(2): 93-100.
[39]Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency ablation of primary thyroid carcinoma: Efficacy according to the types of thyroid carcinoma[J]. Int J Hyperthermia, 2018, 34(5): 611-616.
[40]Cakir B, Topaloglu O, Gul K, et al. Ultrasoundguided percutaneous laser ablation treatment in inoperable aggressive course anaplastic thyroid carcinoma: The introduction of a novel alternative palliative therapy—second experience in the literature[J]. J Endocrinol Invest, 2007, 30(7): 624-625.
[41]Gao M, Ge M, Ji Q, et al. 2016 chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma[J]. Cancer Biol Med, 2017, 14(3): 203-211.
[42]Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign nonfunctioning solid thyroid nodule: A systematic review and metaanalysis[J]. Endocrine, 2020, 67(1): 35-43.
[43]Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: A prospective multicenter study[J]. Korean J Radiol, 2018, 19(1): 167-174.
|